Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 69,438Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 48AbbVie Inc

02 2Aurobindo Pharma Limited

03 2Sandoz B2B

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 15MG

Packaging :

Approval Date : 2019-08-16

Application Number : 211675

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

02

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-01-14

Application Number : 211675

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

03

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 45MG

Packaging :

Approval Date : 2022-03-16

Application Number : 211675

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

04

UPADACITINIB

Brand Name : RINVOQ LQ

Dosage Form : SOLUTION;ORAL

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2024-04-26

Application Number : 218347

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

05

Upadacitinib

Brand Name : Rinvoq

Dosage Form : Modified Release Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 20/01/2020

Application Number : 67257

Regulatory Info : Allowed

Registration Country : Switzerland

Abbvie Company Banner

06

Upadacitinib

Brand Name : Rinvoq

Dosage Form : Extended Release Tablet

Dosage Strength : 30mg

Packaging :

Approval Date : 20/01/2020

Application Number : 67257

Regulatory Info : Allowed

Registration Country : Switzerland

Abbvie Company Banner

07

Upadacitinib

Brand Name : Rinvoq

Dosage Form : Extended Release Tablet

Dosage Strength : 45mg

Packaging :

Approval Date : 20/01/2020

Application Number : 67257

Regulatory Info : Allowed

Registration Country : Switzerland

Abbvie Company Banner

08

Upadacitinib

Brand Name : Rinvoq

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

Abbvie Company Banner

09

Upadacitinib

Brand Name : Rinvoq

Dosage Form : Tablet

Dosage Strength : 30mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

Abbvie Company Banner

10

Upadacitinib

Brand Name : Rinvoq

Dosage Form : Tablet

Dosage Strength : 45mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

Abbvie Company Banner

11

Upadacitinib Hemihydrate

Brand Name : Rinvoq

Dosage Form : Extended-Release Tablet

Dosage Strength : 30MG

Packaging :

Approval Date : 03-09-2021

Application Number : 1191404006

Regulatory Info : Authorized

Registration Country : Spain

Abbvie Company Banner

12

Upadacitinib Hemihydrate

Brand Name : Rinvoq

Dosage Form : Extended-Release Tablet

Dosage Strength : 45MG

Packaging :

Approval Date : 11-10-2022

Application Number : 1191404010

Regulatory Info : Authorized

Registration Country : Spain

Abbvie Company Banner

13

Upadacitinib Hemihydrate

Brand Name : Rinvoq

Dosage Form : Extended-Release Tablet

Dosage Strength : 15MG

Packaging :

Approval Date : 28-01-2020

Application Number : 1191404001

Regulatory Info : Authorized

Registration Country : Spain

Abbvie Company Banner

14

Upadacitinib Hemihydrate

Brand Name : Remove

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 16-12-2019

Application Number : 28106213418

Regulatory Info : Prescription

Registration Country : Denmark

Abbvie Company Banner

15

Upadacitinib Hemihydrate

Brand Name : Remove

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 30mg

Packaging :

Approval Date : 20-08-2021

Application Number : 28106520320

Regulatory Info : Prescription

Registration Country : Denmark

Abbvie Company Banner

16

Upadacitinib Hemihydrate

Brand Name : Remove

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 45mg

Packaging :

Approval Date : 25-07-2022

Application Number : 28106679021

Regulatory Info : Prescription

Registration Country : Denmark

Abbvie Company Banner

17

Upadacitinib Hemihydrate

Brand Name : Remove

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 16-12-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

Abbvie Company Banner

18

Upadacitinib Hemihydrate

Brand Name : Remove

Dosage Form : Tablet

Dosage Strength : 30mg

Packaging :

Approval Date : 20-08-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

Abbvie Company Banner

19

Upadacitinib Hemihydrate

Brand Name : Remove

Dosage Form : Tablet

Dosage Strength : 45mg

Packaging :

Approval Date : 22-07-2022

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

Abbvie Company Banner

20

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2495155

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner